RecruitingPhase 3NCT06810375
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
Sponsor
George Washington University
Enrollment
120 participants
Start Date
Mar 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria1
- Video assisted pulmonary resection, pleurodesis or decortication
Exclusion Criteria3
- Allergy to local anesthetics
- Patient undergoing bilateral surgery
- Surgery is emergent as deemed by the principal investigator
Interventions
DRUGErector Spinae (ESP) Block with Bupivacaine (Marcaine®)
preoperative erector spinae block with bupivacaine (Marcaine®)
DRUGIntercostal nerve block
intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06810375
Related Trials
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Rapid Autopsy and Procurement of Cancer Tissue
NCT018513951 location
General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound
NCT069505151 location
Precision Lung Cancer Survivorship Care Intervention
NCT058579951 location
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
NCT0703834316 locations